Stockreport

Corcept: Korlym Defies Generics As Relacorilant Hits An FDA CRL (Rating Upgrade) [Seeking Alpha]

Corcept Therapeutics Incorporated  (CORT) 
Last corcept therapeutics incorporated earnings: 2/20 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corcept.com/investors
PDF Relacorilant's transition plan faltered after an FDA CRL, delaying lifecycle extension and increasing reliance on KORLYM outcomes. Oncology pipeline, especially relac [Read more]